Correlation of Single Nucleotide Polymorphism (SNP) Profile of Domain III of EGFR to Skin and/or Eye Toxicity and Disease Response to Treatment With Cetuximab or Panitumumab - SNP and Cetuximab or Panitumumab Response
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab; Panitumumab
- Indications Colorectal cancer; Non-small cell lung cancer
- Focus Adverse reactions; Pharmacogenomic
- 26 Feb 2020 Biomarkers information updated
- 17 Dec 2012 New trial record